Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Return to Work after Sick Leave in Kidney Transplant Recipients: A 365-Day Cohort of the Japan Academic Consortium of Kidney Transplantation (JACK) Study
K. Miyake¹, M. Okumi¹, K. Unagami², Y. Kakuta¹, M. Furusawa¹, K. Omoto³, T. Shimizu³, M. Endo⁴, H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Sinjuku, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Sinjuku, Japan, ³Urology, Toda Chuo General Hospital, Saitama, Japan, ⁴Public Health, Juntendo University, Bunkyo, Japan
*Purpose: They said that kidney transplantation was better than dialysis about patient survival and quality of life. However, there have been no large-scale Japanese studies…
2019 American Transplant Congress
The Impact of Reduction of Warm Ischemia on DCD Kidney Transplantation Outcomes
S. Aquil, D. Wonjoon, M. Levine, R. Al Ogaili, A. Sener, P. Luke
Department of Surgery, Multi Organ Transplant Program, Western University Hospital, LHSC, London, ON, Canada
*Purpose: Warm ischemic time (WIT) during donation after cardiac death (DCD) kidney transplantation has significant effects on post-operative outcomes, such as graft survival, function, and…
2019 American Transplant Congress
Utility of a Novel dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients
J. Peabody¹, P. Billings², Z. Demko², D. Paculdo¹, M. Tran¹, S. Moshkevich², C. Valdenor¹
¹QURE Healthcare, San Francisco, CA, ²Natera, Inc., San Carlos, CA
*Purpose: Detecting allograft injury and rejection is critical to preventing graft loss. Current standard of care (SoC) relies on serum creatinine (SC) and biopsy to…
2019 American Transplant Congress
Renal Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis after Kidney Transplantation
N. N. Lam¹, P. Ravani², R. R. Quinn², M. Tonelli², F. Ye¹, B. R. Hemmelgarn², M. M. Sood³
¹University of Alberta, Edmonton, AB, Canada, ²University of Calgary, Calgary, AB, Canada, ³University of Ottawa, Ottawa, ON, Canada
*Purpose: Compared to the general population, kidney transplant recipients are at increased risk of hemorrhage and thrombosis. Whether this risk is affected by kidney function…
2019 American Transplant Congress
Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis
W. Cheungpasitporn¹, C. Thongprayoon², P. Ungprasert³, K. Wijarnpreecha⁴, F. T. Chebib², P. T. Kroner⁴
¹Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, ²Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, ³Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, ⁴Department of Medicine, Mayo Clinic, Jacksonville, FL
*Purpose: This study aimed to evaluate the hospitalization rate for intracerebral hemorrhage (ICH) among renal transplant patients with adult polycystic kidney disease (ADPKD) and its…
2019 American Transplant Congress
Predictive Factors for BKV Nephropathy in Renal Transplant Recipients with BK Viruria
I. Alshaer, M. Bottomley, S. Mehta, J. Galante, I. Roberts, E. Sharples
Renal, Oxford University Hospitals, Oxford, United Kingdom
*Purpose: Polyoma infection due to BK virus remains an important cause of allograft failure following renal transplantation.Intensive monitoring of urine and serum for BK virus…
2019 American Transplant Congress
Outcome Differences in Urine Leak Repair Modality Post Kidney Transplantation
J. Buggs¹, V. Gamarra², E. Rogers¹, R. Watson¹, J. Sokolich¹, H. Pearson¹, J. Huang¹, A. Kumar², V. Bowers¹
¹Tampa General Hospital, Tampa, FL, ²University of South Florida, Tampa, FL
*Purpose: The purpose of this study was to determine differences in outcomes of urine leak treatment modalities post kidney transplantation comparing results of foley catheter,…
2019 American Transplant Congress
Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient
S. C. Jordan¹, R. Vescio², M. Toyoda³, N. Ammerman¹, E. Huang¹, A. Peng¹, S. Sethi¹, R. Najjar¹, K. Lim¹, A. Vo¹
¹Comprehensive Transplant Center, Cedars-Sinai Medical Ctr, Los Angeles, CA, ²Cedars-Sinai Medical Ctr, Los Angeles, CA, ³Transplant Immunology Lab, Cedars-Sinai Medical Ctr, Los Angeles, CA
*Purpose: Antibody-Mediated Rejection (ABMR) is a severe form of rejection mediated by B-cells, plasma cells and antibodies. The consequences to the patients with ABMR are…
2019 American Transplant Congress
Barriers to Kidney Transplant Wait Listing among HIV Positive Patients with Advanced Kidney Disease
S. M. Boyle¹, K. Fehr¹, C. Deering², A. Raza¹, M. Harhay¹, G. Malat³, K. Ranganna¹, D. Lee¹
¹Drexel University, Philadelphia, PA, ²University of Toledo, Toledo, OH, ³Hahnemann University Hospital, Philadelphia, PA
*Purpose: Compared to HIV-negative kidney transplant (KT) candidates, the median time to waiting list activation is longer among HIV-positive candidates. Little is known about potential…
2019 American Transplant Congress
Clinical Utility of a Pharmacogenomic Testing Tool among Kidney Transplant Recipients
S. LeCorchick, L. Lindberg, W. Stapley, S. Anand, D. Morris, T. Srinivas
Kidney/Pancreas Transplant Program, Intermountain Medical Center, Murray, UT
*Purpose: Therapeutic drug monitoring (TDM) for tacrolimus (Tac) is the cornerstone of clinical workflow in the transplant clinic. We report on the clinical implementation of,…